931![Summary Basis of Decision Atriance Summary Basis of Decision Atriance](https://www.pdfsearch.io/img/72422f620b4324846b9ecfa1fbadb7e0.jpg) | Add to Reading ListSource URL: hc-sc.gc.caLanguage: English - Date: 2013-07-12 14:26:36
|
---|
932![QW-NH_DanaFarber_OncologyHemotology_13.pub QW-NH_DanaFarber_OncologyHemotology_13.pub](https://www.pdfsearch.io/img/b683851b3d247f694675a5c61af9b494.jpg) | Add to Reading ListSource URL: quitworksnh.orgLanguage: English - Date: 2013-11-27 12:42:02
|
---|
933![Memorandum Date: 12 September 2010 To: Janet Woodcock, MD Memorandum Date: 12 September 2010 To: Janet Woodcock, MD](https://www.pdfsearch.io/img/641ce817e2c575615b2690819b8bc732.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
934![Memorandum Date: August 8, 2010 From: Memorandum Date: August 8, 2010 From:](https://www.pdfsearch.io/img/fc0ea4d9acd65db97d6d5b135363b865.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
935![Q: What is the herpes simplex virus Q: What is the herpes simplex virus](https://www.pdfsearch.io/img/a2170fa062e9daa4e8ff49bd6140c640.jpg) | Add to Reading ListSource URL: medsask.usask.caLanguage: English - Date: 2013-03-14 12:11:16
|
---|
936![DATE: September 2, 2010 TO: DATE: September 2, 2010 TO:](https://www.pdfsearch.io/img/9bc16643bc8becb832a607d8c18b1cd3.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
937![DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD[removed] DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD[removed]](https://www.pdfsearch.io/img/38cf9c6a4804e37a083b0a2d55038b4a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
938![or increased serum transaminase levels[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVANDARYL ---------------------DOSAGE FORMS AND STRENGTHS------------- or increased serum transaminase levels[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVANDARYL ---------------------DOSAGE FORMS AND STRENGTHS-------------](https://www.pdfsearch.io/img/db89e89d9afb014c3c16185f952a191e.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-12-10 17:21:38
|
---|
939![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOVIRAX Cream safely and effectively. See full prescribing information for ZOVIRAX Cream. ZOVIRAX® (acyclovir) crea HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOVIRAX Cream safely and effectively. See full prescribing information for ZOVIRAX Cream. ZOVIRAX® (acyclovir) crea](https://www.pdfsearch.io/img/398dfd3d65e93be99ecf5d9c868b9a5a.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-04-02 11:26:12
|
---|
940![• Coadministration of AVANDIA and insulin is not recommended. (1.2, 5.3) • Use of AVANDIA with nitrates is not recommended. (1.2, 5.2) ---------------------- DOSAGE AND ADMINISTRATION ---------------• Start at 4 • Coadministration of AVANDIA and insulin is not recommended. (1.2, 5.3) • Use of AVANDIA with nitrates is not recommended. (1.2, 5.2) ---------------------- DOSAGE AND ADMINISTRATION ---------------• Start at 4](https://www.pdfsearch.io/img/45ce3131caeafec9628538fbc6843096.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:08:55
|
---|